I sell when the story plays out. I was close a year ago after Xtandi was off to a fast start. Now with good label expansion possibilities and great results with other compounds I feel there is a lot of gas left in the tank. If I wanted to take the money and run I may have done that after doubling or tripling my money. Now up more than 1200% I find the story more interesting than ever. I did take some chips off the table a year ago, primarily because this had grown to an uncomfortably large percentage of my portfolio. I do find however there is no better place to put my money right now so whats the use? I find most people are too quick to sell their winners and to slow to sell their losers. Funny you mention Warren Buffet, a man you buys and holds "forever". The world is full of people who bought Apple and "took the money and ran" after a 50 or 100% rise and are quite proud of themselves. The ones with balls and the ones who are rich held on for the big ride. To each their own though.
You trust politicians to follow through and yet you claim to be a veteran biotech investor? You are aware that anyone with an iota of knowledge or common sense in this area knows such a move would torpedo the pharmaceutical industry as we know it today. And then on the other hand you say you have no fear of biotechs, well which is it. Your posts have been flip flopping for some time. You sound like a nervous nellie and the things that concern you are things that could affect most any company and this sector you claim to have made a fortune in is ripe with things to worry about. Although what you fear are some of the less likely worries . Your ranting sounds like someone with very little experience. And lastly , where do you get the idea the company is not negotiating in good faith? Try a little patience, I promise, the Politicians will not do anything but blow hot air while this company realises its full potential.
A board you don't trust, politicians you believe can torpedo the company, belief that the only value to a company is not potential drug sales but instead sale of the company itself. Guess you answered my questions, you have no business in this stock or any biotech given your fears. Nothing wrong with that 0.01% interest the bank offers, its as close to s sure thing as you can get at least until Bernie attacks the big banks. Good luck to you and your wife.
With a tiny small cap like this I doubt your explanation. There was huge volume today, presumably someone was buying when someone was selling. More likely a pile of day traders and folks who like to sell the news were responsible for the action today. I do agree we will find its true direction later.
They stated they would prefer not to sell, certainly at that price. But being that there are indication they have hired a firm to guide a possible sale and there are indications they have signed NDA's with two companies your statement that they have no intention of selling would seem to be wrong.
gizmondo123 I understand the newbies here are anxious for a buyout. I am guessing many showed up on the talk of a buyout hoping to make a few dollars and probably know little about the company. You however have been around long enough to have enjoyed some of the success this board had led us to. Whats the rush? If there are companies interested now what will happen if we get some good results from the other compounds or further expansion of Xtandi or perhaps both? If you have so little faith in the board we know and want to throw in with those you don't than you are probably invested in the wrong company. If you're worried about what Bernie Sanders may do your invested in the wrong sector. And lastly what will you do with your money if there is a buyout? Are you aware of a better run company with as bright of prospects? If so please share.
I haven't ever seen a $50-100 rise on approval. And in this case it was largely assumed it would get approved so much of the increase is already baked in.
Of course the conniving SNY company does not wish to spend $60 + a share so they could not accumulate a meaningful number of shares.
Your reasons for Braeburn to buy Titan are the same reasons Titan would not wish to sell. It takes two to tango as they say.
I have never seen that happen. Usually there is a buyout press release followed by a conference call. Not sure I have ever see a buyout announced immediately after a FDA approval either. Whats the rush?
Stock lurker That explains why there was no mention of this until now, it simply doesn't apply.
Perhaps they are talking to all legitimate bidders, and SNY is not legitimate. They told SNY their offer was way to low. The ball is in SNY's court to come back with an offer that is not, otherwise they are no more a legitimate bidder than me.
I am sure there are behind the scene conversations that we are not aware of, including a likely minimum price suggestion from MDVN. What we do know is SNY made an offer well below what MDVN feels the company is worth.
If you wish to buy a house or a car, especially one that is not actually for sale, you need to make a strong bid or you will kill your chances of entering into negotiations. SNY's strategy of a lowball price during a rather opportune time of lows in the biotech sector was an obvious attempt to rob the current shareholders. As a stockholder you should applaud management's efforts to get you full value. SNY can certainly raise its offer but they have already created bad blood so they continue with their hopes of getting a steal by replacing the board.
MDVN holds most of the cards. They likely have been in contact with major shareholders and have an idea of how the vote will go. They also know what if any other interest there is in the company and perhaps there are even some price suggestions being thrown around.
Do you trust the current board that has guided a company to one major drug approval and a couple more potential blockbusters in the wing? A board that has overseen a stock that has gone up 10 fold in five years. If you don't trust their judgement and tactics you may wish to invest elsewhere. If you find a better run company with similar prospects I would love to know about it.
So whats the significance of the $38 dollar base that you and Sanofi are so enamored with? That was near a yearly low during a big funk hanging over the sector. Why not discuss the yearly high or the current price, both in the 60's, along with your "facts". The stock price at any given moment doesn't tell you a whole lot. And Sanofi is the one that wants a deal, MDVN was happy as a stand alone. If you want what someone else has you should be prepared to pay for it.
According to Bloomberg, Celgene (NASDAQ:CELG) is considering a bid for Medivation (NASDAQ:MDVN), currently trying to hold off Sanofi (NYSE:SNY). Other suitors supposedly in the mix are Pfizer (NYSE:PFE), AstraZeneca (NYSE:AZN) and Amgen (NASDAQ:AMGN).
Sanofi is playing a childish game, they say give us information and we will increase our offer. There is nothing to prohibit them from upping their offer in order to get back into the good graces of Medivation. They need to come back with a $10+ bump in offer price to even be considered as a player. Their end around hostile attempt is a long shot and will still require increasing their bid. Why not just raise the bid now?
True but $80 tastes a lot better than $52.50. Not sure there would be much in the way of opposition to that price unless they suddenly develop a cure for baldness.
This was written in 2015
A study by Credit Suisse indicates that, since 1995, only 38% of hostile takeover bids have proved successful. According to the study, the size of the deal makes no difference to the chances of success, but it does point out that no hostile takeover bid over $10 billion has been successfully completed since Amgen acquired biotechnology company Onyx two years ago.
I could see this working if there was currently an inept board driving the company into the ground. But given this company's success with its drugs and the huge stock price increase over the last decade it would amaze me if they get even a smattering of votes.